Article
β-Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defects.
The Journal of biological chemistry - 9 Nov 2012
Hitt Brian, Riordan Sean M, Kukreja Lokesh, Eimer William A, Rajapaksha Tharinda W, Vassar Robert
Abstract excerpt
BACE1 is the β-secretase enzyme that initiates production of the β-amyloid peptide involved in Alzheimer disease. However, little is known about the functions of BACE1. BACE1-deficient mice exhibit mild but complex neurological phenotypes suggesting therapeutic BACE1 inhibition may not be completely free of mechanism-based side effects. Recently, we have reported that BACE1 null mice have axon guidance defects in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
